Purchase of activin to conduct cell therapy project at the national eye institute [18-003288]
Ended Awarded
- Contract number
- HHSN30100002
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,545
Award facts
- Contract value 100% obligated
- $22,545.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
The National Eye Institute awarded a $22,545 firm fixed price BPA call contract to Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation. The contract, awarded on March 7, 2018, with an ultimate completion date of August 31, 2018, was issued to procure Activin for a cell therapy project at the Institute. This non-set-aside purchase was executed as a call under an existing blanket purchase agreement, allowing the National Eye Institute to obtain specialized biological reagents through a pre-competed vehicle. R&D Systems has an established track record as a critical supplier to the National Institutes of Health ecosystem, regularly providing recombinant human proteins, growth factors, and specialized research reagents to support biomedical research across multiple NIH institutes.
The procurement reflects the National Eye Institute's research infrastructure needs for cell therapy development, leveraging R&D Systems' expertise in producing high-quality proteins and bioactive reagents. The relatively modest contract value indicates a targeted purchase of specific quantities of Activin, a transforming growth factor superfamily protein commonly used in stem cell and developmental biology research. As a subsidiary of Bio-Techne Corporation, R&D Systems benefits from its parent company's comprehensive portfolio of life sciences tools and established relationships with federal research agencies, positioning it to efficiently fulfill specialized research supply requirements for federal laboratories and clinical research initiatives.
Quick answers
Who was awarded contract HHSN30100002?
HHSN30100002 was awarded to Research And Diagnostic Systems, Inc. by National Eye Institute (National Institutes of Health) on March 7, 2018.
How much is contract HHSN30100002 worth?
The government has obligated $22,545 on HHSN30100002.
Is contract HHSN30100002 an order under another contract?
Yes. HHSN30100002 is a BPA call under HHSN263201600021B, a blanket purchase agreement.
Was contract HHSN30100002 competed?
The extent of competition for HHSN30100002 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award